Investor Fights Illumina's Poison Pill Against Roche Bid
Gene-sequencing firm Illumina Inc. was hit Tuesday with a proposed shareholder class action intended as an antidote to the company's recent poison pill efforts to resist a hostile takeover by Roche...To view the full article, register now.
Already a subscriber? Click here to view full article